£1.7M
Foresight Williams Technology led the oversubscribed round alongside several regional and specialist investors.
Nebu~Flow develops advanced nebuliser technology for respiratory medicine.
A medical device developer creating surface acoustic wave nebulisers designed to handle next-generation respiratory pharmaceuticals.

Elijah Nazarzadeh
CEO
Elijah serves as CEO at Nebu~Flow. His background includes research roles at the University of Glasgow, King's College London, and the Phillips Hydrocolloid Research Centre.
LinkedInForesight Williams Technology led the oversubscribed round alongside several regional and specialist investors.